It has been reported that patients who suffer from prostate cancer have two times more chances of suffering blood clots, which can lead to DVT, deep vein thrombosis.

Those more at risk of DVT are men who are undergoing a hormone therapy for the disease and men who are young but have advanced-stage cancer.

About 76,000 Swedish men were studied before reaching to a conclusion and the rates of thromboembolic diseases, which include DVT and pulmonary embolism (PE), were looked at in these men. It was found that in general population they occurred more often in men with prostate cancer.

Reasons have not yet been established for cancer and its various treatments posing as risk factors for thromboembolism as it has not been found whether the difference in risk seen has taken place due to the treatment itself or other physiological factors.